RudaCure participó in the RESI (Redefining Early Stage Investments) Conference and fue seleccionada como 3rd place out of 70 empresas in the Innovator's Pitch Challenge.
The RESI Conference, celebrado en Boston from September 21–23, was asistió by RudaCure — participating through the Shinhan Square Bridge programa — along with aproximadamente 70 other empresas.
Nos gustaría agradecer a the Shinhan Square Bridge team in Korea for preparing the event,
and the KIC representatives we met through Boston meetings alongside this event, as well as OraTeam and NEMIC_Team for their valuable advice.
También estamos grateful to THEA_Team and Santen_Team for their interest in RCI001 and the many ideas they shared. We will maintain this ongoing relationship to ensure a successful outcome for RCI001 ensayo clínicos.
